TSE:BN

Brookfield Corp (BN.TO)

62.27
-1.21 (1.91%)
as of Jun 10, 2026, 8:00:01 pm Market Open.
280 watching
0
Investor Insights
star iconJun 11, 2026, 12:00 am

This summary was created by AI, based on 51 opinions in the last 12 months.

Brookfield Corp (BN-T) is widely regarded as a strong core holding among analysts, valued for its strong positioning in the alternative asset management space. Many experts highlight the company's diversified investment approach, particularly in sectors such as infrastructure and private equity, amidst rising interest rate concerns. Despite recent volatility, the stock is seen as trading at an attractive valuation, particularly with a potential upside noted against its net asset value (NAV). Analysts also emphasize the benefits of owning the parent company over its subsidiaries to capture broader income streams and management efficiency. Overall, the company's long-term growth prospects remain robust, driven by continuous capital deployment and record distributable earnings.

consensus icon
Consensus
Buy
valuation icon
Valuation
Undervalued
review icon
Similar
BAM
DON'T BUY

He hasn't warmed up to the Brookfield companies. This restructuring is a bit of a shell game. He prefers a pure play stock. But if he prefers the Renewables stock the most given its growth prospects.

PAST TOP PICK
(A Top Pick Aug 14/23, Down 12%)

Stock overhang due to commercial real estate portfolio. Still thinks overall - real estate will be strong. Interest rates will put pressure on company in mid term. Long term is a strong business. Excellent ability to raise money. Will continue to own shares. 

BUY

Insurance business very strong. Ability to raise capital very good. High quality management team. Diverse array of assets. Would hold for the long term. 

SELL
Sell BAM and BN to buy Brookfield Reinsurance

He's very negative and expects 17% downside. No, negative trend yet, but doesn't like the Brookfield companies. Why are there three Brookfield companies in the index? $40.85 is his target.

BUY

It has good assets and good access to capital. This means it can buy assets with declining prices and there are global opportunities as well. It is at a good entry point to buy for the long term.

BUY

Two really well-run companies. 

BN is the parent company for all the subsidiaries. A wonderful compounder. Negative sentiment around real estate holdings, which are high quality and global. Capital allocation opportunities will benefit shareholders. Loves it, he'd buy right here.

For BIP.UN, a wonderful income opportunity. You get growth and income. He'd be a buyer of this one, too. Valuation discount to BN. 

BUY

What's hurt it is their large commercial property portfolio, though an excellent AAA one. BN trading at a 30% discount to NAV. Now is a good time to look at BN at these levels. Historically, they've narrowed the NAV over time.

BUY ON WEAKNESS

All the Brookfield offerings are extremely well-managed companies. Fair amount of leverage built in, as demonstrated by recent volatility. When the price is depressed, that's the time to look. Expects dividend increases. All are good, and BN is probably one of the better ones.

WEAK BUY
BN vs. BIP.UN

Problem in last year has been its real estate holdings with interest rates going up as much as they have. Sometimes the satellites are the better way to play. Both work, but BIP.UN is the better choice right now with it being as cheap as it is and growing at 10%. 

BUY

Many dislike this for owning a lot of real estate, but if you add up all the publicly traded companies that BN owns, you get the real estate for free. A worthwhile investment and you should buy. The best-managed conglomerate in Canada.

PAST TOP PICK
(A Top Pick Nov 09/22, Up 2%)

They spun off the asset manager, and this is the core company. The tickers are confusing. This is the mothership to its affiliate companies and stocks. This is a great compounder over 3 decades and continues to be so. He continues to buy this.

DON'T BUY
BN vs. BAM

Over the next year interest rates should reverse, so we should see some good pickup in stocks that are yield plays. Not looking for big gains on these types of stocks.

Chart for BN shows the common pattern of a peak in 2021, and then a decline in 2022. Lots of correlation with the market. Now the stock's bottoming out, and we'll have to see where the next trend is. Decent support around $41, so you're OK if it stays above that. So many other stocks to choose from, he wouldn't touch this one.

BAM has been consolidating. Hard to trade, as the trading range is quite narrow. It's a buy from a yield perspective. If it breaks above $48 and hits a new level, a whole new round of buyers will come in. Holds it for some clients as a way to diversify.

TOP PICK

It is a good long term investor holding shares of other Brookfield companies as well as having an insurance arm. The stock price is reflecting concerns over real estate exposure. However the market is giving it zero value for this and its commercial holdings are at the premium end which are not as affected as the lower end holdings. There have been a couple of defaults but this is not a concern. Brookfield has provided good returns over time.
Buy 9  Hold 2  Sell 1

(Analysts’ price target is $60.07)
PAST TOP PICK
(A Top Pick Jan 10/23, Down 2%)

Real estate has been the stumbling block, especially office space. Might be up and down in the short term. In the long run, owns best-in-class properties. Management has been around a while.

DON'T BUY

The chart has been quite volatile this year, all over the place, choppy. The elephant in the room is the cost of capital in the real estate sector. If you own this, watch the 12-month of low of $41; if it breaks below that, there's likely more selling to come. If you want dividends, look elsewhere.

Showing 121 to 135 of 175 entries